You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BRCA1-Associated Protein-1

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mesothelioma, Malignant Mesothelioma (MM), Early-stage Mesothelioma Trial run by the National Cancer Institute (NCI)

Not yet recruiting
  • Mesothelioma
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 1, 2023

Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma Trial (Nab paclitaxel,

Not yet recruiting
  • Pancreatic Acinar Cell Carcinoma
  • +6 more
  • Nab paclitaxel
  • +5 more
  • (no location specified)
Oct 30, 2023

Breast Cancer Trial in Tucson, Albuquerque (Pegylated liposomal doxorubicin)

Completed
  • Breast Cancer
  • Pegylated liposomal doxorubicin
  • Tucson, Arizona
  • +1 more
Jan 9, 2023

Serum Retinoic Acid Induced Protein 14 and Metastasis Associated

Not yet recruiting
  • Breast Cancer
  • laboratory test (RAI14 and MACC-1 )
  • (no location specified)
Oct 18, 2023

Breast Cancer, Ovarian Cancer, Pancreas Cancer Trial (TNG348, Olaparib)

Not yet recruiting
  • Breast Cancer
  • +7 more
  • (no location specified)
Sep 26, 2023

Triple Negative Breast Tumors, Triple Negative Breast Cancer, Breast Tumors Trial (Pembrolizumab, Paclitaxel, Carboplatin)

Not yet recruiting
  • Triple Negative Breast Neoplasms
  • +7 more
  • (no location specified)
Aug 1, 2022

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Serous Adenocarcinoma Trial in Buffalo, New York (biological, other, drug)

Active, not recruiting
Has Results
  • BRCA1 Gene Mutation
  • +5 more
  • Durvalumab
  • +3 more
  • Buffalo, New York
  • +1 more
Jan 20, 2023

Ultra-rapid BRCA1/2 Status Screening Test in Theranostic

Not yet recruiting
  • Breast Cancer
  • Questionnaires
  • Communication of the results of the BRCA1/2 ultra rapid test
  • (no location specified)
Oct 26, 2023

Germline Variant Carriers With BRCA1 or BRCA2

Recruiting
  • BRCA1 and/or BRCA2 Variant Carriers
  • +3 more
    • Okayama, Japan
      Okayama University
    Dec 25, 2022

    Breast Cancer, Ovarian Cancer, Breast Tumors Trial in Dnipro, Kyiv (Axitinib)

    Enrolling by invitation
    • Breast Cancer
    • +7 more
    • Dnipro, Ukraine
    • +1 more
    Jun 17, 2023

    BRCA1/2 Flu Vaccine

    Active, not recruiting
    • BRCA1 Mutation
    • BRCA2 Mutation
    • Seasonal influenza vaccine
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Aug 16, 2022

    Breast Tumors Trial in Worldwide (KU-0059436 (AZD2281) (PARP inhibitor))

    Completed
    Has Results
    • Breast Neoplasms
    • KU-0059436 (AZD2281) (PARP inhibitor)
    • West Hollywood, California
    • +16 more
    Jan 24, 2023

    Ovarian Tumors, BRCA1 Protein, BRCA2 Protein Trial in Worldwide (KU-0059436 (AZD2281)(PARP inhibitor))

    Active, not recruiting
    • Ovarian Neoplasms
    • +2 more
    • KU-0059436 (AZD2281)(PARP inhibitor)
    • Brussels, Belgium
    • +4 more
    Dec 19, 2022

    BRCA1 Mutation, BRCA2 Mutation, Ovarian Cancer Trial in Providence (Talazoparib Oral Capsule)

    Active, not recruiting
    • BRCA1 Mutation
    • +4 more
    • Talazoparib Oral Capsule
    • Providence, Rhode Island
    • +1 more
    Nov 30, 2022

    Breast Cancer, Genetic Predisposition Trial in Rome, Varese (Genetic predisposition to breast cancer)

    Recruiting
    • Breast Cancer
    • Genetic Predisposition
    • Genetic predisposition to breast cancer
    • Rome, Italy
    • +1 more
    May 4, 2023

    PREDICTION OF GERMLINE BRCA 1/2 GENES FROM HEALTHY OVARIES

    Not yet recruiting
    • BRCA Mutation
    • +2 more
    • Germinal BRCA
    • (no location specified)
    Mar 3, 2023

    Breast Cancer BRCA1 Carriers: a Pilot Study

    Withdrawn
    • BRCA1 Mutation
    • +2 more
    • Mifepristone 200 MG
    • Prophylactic mastectomy
    • Carmel, Indiana
    • +1 more
    Dec 13, 2022

    Germline Mutations Associated With Hereditary Pancreatic Cancer

    Recruiting
    • Pancreatic Cancer
    • Pancreatic Adenocarcinoma
    • Invitae Multi-Cancer Panel ®
    • Mexico City, Mexico
      Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
    Mar 22, 2022

    Endocrine Disruptors and Life STILe in Breast Cancer Development

    Recruiting
    • Breast Cancer
    • +5 more
      • Roma, Italy
        Alessandra Fabi
      Feb 25, 2023

      Cystatin D Fibrinogen Like Protein 1

      Not yet recruiting
      • Fibrinogen Like Protein 1
      • ELISA TEST
      • (no location specified)
      Jun 26, 2023

      Breast Cancer, Metastatic Breast Cancer, BRCA1 Gene Mutation Trial in Boston (ABT-888, temozolomide)

      Active, not recruiting
      • Breast Cancer
      • +3 more
      • Boston, Massachusetts
      • +2 more
      Dec 21, 2022

      BRCA and NACT in TNBC Patients

      Completed
      • Triple-Negative Breast Cancer
      • BRCA1/2 genetic testing
      • Rome, RM, Italy
        Fondazione Policlinico Universitario Agostino Gemelli IRCCS
      Feb 20, 2023

      Breast Cancer After Ovarian Cancer During and/or After Therapy:

      Recruiting
      • BRCA-Associated Breast Carcinoma
      • Next-generation sequencing (NGS) assay TruSight Oncology 500 (TSO 500).
      • Rome, RM, Italy
        Fondazione Policlinico Universitario Agostino Gemelli IRCCS
      Mar 9, 2023

      l, Laboratory and Epidemiologic Characterization of Individuals

      Completed
      • Familial Ovarian Cancer
      • +3 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Dec 31, 2022

        Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors

        Recruiting
        • Breast Cancer
        • +3 more
          • Stanford, California
            Stanford University School of Medicine
          Sep 2, 2021